Beth Overmoyer

Beth Overmoyer

UNVERIFIED PROFILE

Are you Beth Overmoyer?   Register this Author

Register author
Beth Overmoyer

Beth Overmoyer

Publications by authors named "Beth Overmoyer"

Are you Beth Overmoyer?   Register this Author

50Publications

1401Reads

44Profile Views

Inflammatory Breast Cancer: a Separate Entity.

Curr Oncol Rep 2019 Aug 15;21(10):86. Epub 2019 Aug 15.

Susan F. Smith Center for Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0842-yDOI Listing
August 2019

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study.

J Clin Oncol 2018 05 20;36(13):1317-1322. Epub 2018 Mar 20.

Reshma Jagsi, Felix Y. Feng, Corey Speers, Michael Sabel, Anne F. Schott, and Lori Pierce, University of Michigan; Kent A. Griffith, University of Michigan School of Public Health, Ann Arbor, MI; Jennifer R. Bellon and Beth Overmoyer, Dana-Farber Cancer Institute, Boston, MA; Wendy A. Woodward, The University of Texas MD Anderson Cancer Center, Houston, TX; Janet K. Horton, Duke University School of Medicine, Durham, NC; and Alice Ho, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.77.2665
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.77.2665DOI Listing
May 2018

Vocal fold paralysis on positron emission tomography-CT.

Thorax 2018 01 17;73(1):97-98. Epub 2017 Jul 17.

Department of Pulmonary and Critical Care Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2016-209261DOI Listing
January 2018

Treatment with adjuvant endocrine therapy for early-stage breast cancer: is it forever?

Authors:
Beth Overmoyer

J Clin Oncol 2015 Mar 26;33(8):823-8. Epub 2015 Jan 26.

Dana-Farber Cancer Institute, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.2361DOI Listing
March 2015

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

N Engl J Med 2015 Jan;372(2):134-41

From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1406281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313867PMC
January 2015

What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.

Radiographics 2013 Nov-Dec;33(7):2003-17

From the Division of Breast Imaging, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, RA Bldg, RA-014, Boston, MA 02115 (E.D.Y., R.L.B., D.G.S., C.S.G.); and Department of Imaging (H.A.J., A.D.V.d.A.), Department of Radiation Oncology (J.R.B.), Department of Surgery (F.N.), Department of Breast Oncology (B.O.), and Inflammatory Breast Cancer Program (E.D.Y., H.A.J., J.R.B., F.N., J.H.B., B.O.), Dana-Farber Cancer Institute, Boston, Mass.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.337135503DOI Listing
June 2014

Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.

Ann Surg Oncol 2013 Mar 7;20(3):811-8. Epub 2012 Sep 7.

Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1245/s10434-012-2640-8
Publisher Site
http://dx.doi.org/10.1245/s10434-012-2640-8DOI Listing
March 2013

A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.

Int J Radiat Oncol Biol Phys 2012 Jan 29;82(1):14-20. Epub 2010 Oct 29.

Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.08.051DOI Listing
January 2012

Case records of the Massachusetts General Hospital. Case 17-2011. A 49-year-old woman with a mass in the breast and overlying skin changes.

N Engl J Med 2011 Jun;364(23):2246-54

Department of Medical Oncology, Dana–Farber Cancer Institute, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc1100922DOI Listing
June 2011

Inflammatory breast cancer: novel preoperative therapies.

Authors:
Beth A Overmoyer

Clin Breast Cancer 2010 Feb;10(1):27-32

Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.003DOI Listing
February 2010

Options for the treatment of patients with taxane-refractory metastatic breast cancer.

Authors:
Beth Overmoyer

Clin Breast Cancer 2008 Mar;8 Suppl 2:S61-70

Deparment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
March 2008

Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.

Invest New Drugs 2007 Apr 13;25(2):161-4. Epub 2006 Sep 13.

Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-9007-6DOI Listing
April 2007

Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.

Breast J 2006 Jan-Feb;12(1):28-36

Department of Radiation Oncology, University Hospitals of Cleveland, Cleveland, Ohio 44106-5000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1075-122X.2006.00181.xDOI Listing
April 2006

Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer.

Clin Breast Cancer 2005 Jun;6(2):150-7

Department of Medicine, Case Western Reserve University, Cleveland, OH 44106-5055, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2005.n.017DOI Listing
June 2005

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.

Cancer Chemother Pharmacol 2005 Mar 6;55(3):295-300. Epub 2004 Nov 6.

Developmental Therapeutics Program, CASE Comprehensive Cancer Center, University Hospitals of Cleveland, 211100 Euclid Avenue, Cleveland, OH, 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0871-5DOI Listing
March 2005

Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer.

Clin Cancer Res 2004 Jan;10(1 Pt 1):96-100

Division of Hematology, Department of Medicine, Case Western Reserve University (CWRU), School of Medicine, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
January 2004

Combination chemotherapy for metastatic breast cancer: reaching for the cure.

Authors:
Beth Overmoyer

J Clin Oncol 2003 Feb;21(4):580-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.10.085DOI Listing
February 2003